Coeptis Therapeutics is a drug development company that creates cancer treatments and cell therapy tools. The company offers CD38-GEAR-NK, a drug for cancer treatment, and CD38-Diagnostic, a screening tool to help determine the efficacy of specific anti-CD38 monoclonal antibodies therapies. Coeptis also has partnerships with other biopharmaceutical companies to develop and commercialize STAT-201 for Crohn's disease and CPT60621 for Parkinson's Disease.